99055-81-9

Usage

Uses

Used in Pharmaceutical Industry:
N,N-Dimethyl-1H-indazole-3-carboxamide is used as a pharmaceutical compound for its potential anti-inflammatory and analgesic effects. Its pharmacological activities make it a candidate for the development of new drugs targeting inflammation and pain management.
Used in Chemical Industry:
N,N-Dimethyl-1H-indazole-3-carboxamide is used as a synthetic intermediate in the chemical industry for the synthesis of other organic compounds. Its unique structure and properties contribute to the creation of novel chemical entities with potential applications in various fields.

Upstream product

• 124-40-3 dimethyl amine 
• 43120-28-1 methyl 1H-indazole-3-carboxylate 
• 4498-67-3 1H-Indazole-3-carboxylic acid 
• 115660-68-9 diindazolo<2,3-a,2',3'-d>pyrazine-7,14-dione 

Downstream Products

• 142910-86-9 1-(1H-indazol-3-yl)-N,N-dimethylmethanamine 

Relevant academic research and scientific papers

INDAZOLE DERIVATIVES

The present invention provides a compound represented by Formula (I): [whetein R1 represents CONR1aR1b (wherein R1a and R1b may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted ararkyl or a substituted or unsubstituted heterocyclic group, or R1a and R1b are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group) or the like, R2 represents a hydrogen atom, CONR2aR2b (wherein R2a and R2b may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl, substituted or unsubstituted ararkyl or a substituted or unsubstituted heterocyclic group, or R2a and R2b are combined together with the adjacent nitrogen atom thereto to form a substituted or unsubstituted heterocyclic group), NR2cR2d (wherein R2c and R2d may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkanoyl, substituted or unsubstituted aroyl, substituted or unsubstituted heteroaroyl, substituted or unsubstituted ararkyl, substituted or unsubstituted lower alkylsulfonyl or substituted or unsubstituted lower arylsulfonyl) or the like].

PROTEIN KINASE INHIBITOR

The present invention provides a protein kinase inhibitor (excluding c-Jun N-terminal kinase inhibitor) which comprises, as an active ingredient, an indazole derivative represented by Formula (I) (wherein R1 represents substituted or unsubstituted aryl or a substituted or unsubstituted heterocyclic group) or a pharmaceutically acceptable salt thereof.